PT - JOURNAL ARTICLE AU - Boogaerts Tim AU - Lotte Jacobs AU - Naomi De Roeck AU - Siel Van den Bogaert AU - Bert Aertgeerts AU - Lies Lahousse AU - Alexander L.N. van Nuijs AU - Peter Delputte TI - An alternative approach for bioanalytical assay development for wastewater-based epidemiology of SARS-CoV-2 AID - 10.1101/2021.02.12.21251626 DP - 2021 Jan 01 TA - medRxiv PG - 2021.02.12.21251626 4099 - http://medrxiv.org/content/early/2021/02/13/2021.02.12.21251626.short 4100 - http://medrxiv.org/content/early/2021/02/13/2021.02.12.21251626.full AB - Wastewater-based epidemiology could be applied to track down SARS-CoV-2 outbreaks at high spatio-temporal resolution and could potentially be used as an early-warning for emergence of SARS-CoV-2 circulation in the general population. Epidemiological surveillance of SARS-CoV-2 could play a role in monitoring the spread of the virus in the population and controlling possible outbreaks. However, sensitive sample preparation and detection methods are necessary to detect trace levels of SARS-CoV-2 RNA in influent wastewater (IWW).Unlike predecessors, method development of a SARS-CoV-2 RNA concentration and detection procedure was performed with IWW samples with high viral SARS-CoV-2 loads (in combination with seeding IWW with a surrogate coronavirus). This is of importance since the SARS-CoV-2 genome in IWW might have already been subject to in-sewer degradation into smaller genome fragments or might be present in a different form (e.g. cell debris,…). Centricon Plus-70 (100 kDa) centrifugal filter devices resulted in the lowest and most reproducible Ct-values for SARS-CoV-2 RNA. Lowering pore sizes did not improve our limit of detection and quantification. Real-time polymerase chain reaction (qPCR) was employed for the amplification of the N1, N2, N3 and E_Sarbeco-gene.This is one of the first studies to apply digital polymerase chain reaction (dPCR) for the detection of SARS-CoV-2 RNA in IWW. Interestingly, qPCR results were comparable with dPCR results suggesting that qPCR is a valid method. In this study, dPCR was also used as a proxy to assess the precision of qPCR. In this light, dPCR showed high variability at low concentration levels (100 copies/µL), indicating that variability in bioanalytical assays for SARS-CoV-2 RNA might be substantial.On average, the N2-gene showed high in-sample stability in IWW for 10 days of storage at 4 °C. Between-sample variability was substantial due to the low native concentrations in IWW. Additionally, the E-gene proved to be less stable compared to the N2-gene and showed higher variability. Freezing the IWW samples resulted in a 10-fold decay of loads of the N2- and E-gene in IWW.Although WBE can already aid in filling some knowledge gaps in the epidemiological surveillance of SARS-CoV-2, future WBE studies should aim to further validate and standardize bioanalytical assays, especially with regards to methodological limitations.HighlightsDevelopment of an analytical procedure for detection of SARS-CoV-2 RNA in wastewaterExtraction recovery was evaluated in influent wastewaterPrecision measured with dPCR used as a proxy for qPCRqPCR of the N2 gene fragment showed high in-sample stability of SARS-CoV-2 on averageCompeting Interest StatementThe authors have declared no competing interest.Funding StatementThe funding of this project was obtained from the Research Council (BOF) of the University of Antwerp [project number: FFB200184] and the Agency of Care and Health [project number: GE0-1GPFZJA-WT]. Additionally, we thank the personnel of Aquafin for their support in collection of the IWW samples.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study did not include clinical trial data and ethical approval was not required.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are given in the manuscript and supplementary information.